BD to Announce Financial Results for its First Quarter of Fiscal 2023

06 January 2023 | Friday | News

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023.
Picture Courtesy : Public Domain

Picture Courtesy : Public Domain

A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's first quarter of fiscal year 2023, which ended on Saturday, December 31, 2022.

BD management will host an audio webcast at 8 a.m. ET on February 2, 2023 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close